Concepedia

Sylvain Cottens

SC

Statistics

Publications

21

Citations

4.1K

H-Index

17

Active since

1984

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Scripps Research Institute

Institut de Chimie

University of Lausanne

Sylvain Cottens is an author at Novartis (Switzerland) specializing in medicine, natural sciences, and biochemistry.

Top concepts

Publications per year

1984–2019

21

Publications

21

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text

, , +16

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

Gabriele Weitz‐Schmidt, Karl Welzenbach, Volker Brinkmann et al. · Nature Medicine · 2001 · 1K citations

, , +8

SDZ RAD, A NEW RAPAMYCIN DERIVATIVE

W. Schüler, Richard Sedrani, Sylvain Cottens et al. · Transplantation · 1997 · 536 citations

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain 1 1Edited by F. E. Cohen

Joerg Kallen, Karl Welzenbach, Paul Ramage et al. · Journal of Molecular Biology · 1999 · 256 citations

, , +13

The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation

Jean-Pierre Evenou, Jürgen Wagner, Gerhard Zenke et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 159 citations

1–5 of 21